These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 10669071)

  • 1. A comparison of the harms associated with the injection of heroin and amphetamines.
    Kaye S; Darke S
    Drug Alcohol Depend; 2000 Feb; 58(1-2):189-95. PubMed ID: 10669071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
    McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
    Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of drug use and risk-taking among injecting amphetamine and opioid drug users in Sydney, Australia.
    Hall W; Darke S; Ross M; Wodak A
    Addiction; 1993 Apr; 88(4):509-16. PubMed ID: 8485428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Transitions between the injection of heroin and amphetamines.
    Darke S; Kaye S; Ross J
    Addiction; 1999 Dec; 94(12):1795-803. PubMed ID: 10717958
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing popularity of injection as the route of administration of amphetamine in Edinburgh.
    Peters A; Davies T; Richardson A
    Drug Alcohol Depend; 1997 Dec; 48(3):227-34. PubMed ID: 9449022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV infection and risk behaviour of primary fentanyl and amphetamine injectors in Tallinn, Estonia: implications for intervention.
    Talu A; Rajaleid K; Abel-Ollo K; Rüütel K; Rahu M; Rhodes T; Platt L; Bobrova N; Uusküla A
    Int J Drug Policy; 2010 Jan; 21(1):56-63. PubMed ID: 19395249
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Polydrug Use and Heterogeneity in HIV Risk Among People Who Inject Drugs in Estonia and Russia: A Latent Class Analysis.
    Tavitian-Exley I; Boily MC; Heimer R; Uusküla A; Levina O; Maheu-Giroux M
    AIDS Behav; 2018 Apr; 22(4):1329-1340. PubMed ID: 28699018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Injecting risk behaviour and related harm among men who use performance- and image-enhancing drugs.
    Larance B; Degenhardt L; Copeland J; Dillon P
    Drug Alcohol Rev; 2008 Nov; 27(6):679-86. PubMed ID: 18825549
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of benzodiazepines among regular amphetamine users.
    Darke S; Ross J; Cohen J
    Addiction; 1994 Dec; 89(12):1683-90. PubMed ID: 7866252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Severity of heroin dependence and HIV risk. II. Sharing injecting equipment.
    Gossop M; Griffiths P; Powis B; Strang J
    AIDS Care; 1993; 5(2):159-68. PubMed ID: 8392383
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of a reduction in heroin availability on patterns of drug use, risk behaviour and incidence of hepatitis C virus infection in injecting drug users in New South Wales, Australia.
    Maher L; Li J; Jalaludin B; Wand H; Jayasuriya R; Dixon D; Kaldor JM
    Drug Alcohol Depend; 2007 Jul; 89(2-3):244-50. PubMed ID: 17289299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stimulant injectors in Ukraine: the next wave of the epidemic?
    Booth RE; Lehman WE; Kwiatkowski CF; Brewster JT; Sinitsyna L; Dvoryak S
    AIDS Behav; 2008 Jul; 12(4):652-61. PubMed ID: 18264752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HIV-risk behaviour among non-heroin using cocaine injectors and non-injectors in São Paulo, Brazil.
    Dunn J; Laranjeira RR
    AIDS Care; 2000 Aug; 12(4):471-81. PubMed ID: 11091780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Injecting and sexual risk-taking behaviour among regular amphetamine users.
    Darke S; Ross J; Cohen J; Hando J; Hall W
    AIDS Care; 1995; 7(1):19-26. PubMed ID: 7748906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of injecting drug use and associated risk behavior among regular ecstasy users in Australia.
    White B; Day C; Degenhardt L; Kinner S; Fry C; Bruno R; Johnston J
    Drug Alcohol Depend; 2006 Jul; 83(3):210-7. PubMed ID: 16343810
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Continuing drug risk behaviour: shared use of injecting paraphernalia among London heroin injectors.
    Gossop M; Griffiths P; Powis B; Williamson S; Fountain J; Strang J
    AIDS Care; 1997 Dec; 9(6):651-60. PubMed ID: 26672149
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transitions between routes of administration of regular amphetamine users.
    Darke S; Cohen J; Ross J; Hando J; Hall W
    Addiction; 1994 Sep; 89(9):1077-83. PubMed ID: 7987184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence and correlates of the injection of methadone syrup in Sydney, Australia.
    Darke S; Ross J; Hall W
    Drug Alcohol Depend; 1996 Dec; 43(3):191-8. PubMed ID: 9023075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential risk factors for the transition to injecting among non-injecting heroin users: a comparison of former injectors and never injectors.
    Neaigus A; Miller M; Friedman SR; Hagen DL; Sifaneck SJ; Ildefonso G; des Jarlais DC
    Addiction; 2001 Jun; 96(6):847-60. PubMed ID: 11399216
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HIV risks for women drug injectors: heroin and amphetamine users compared.
    Klee H
    Addiction; 1993 Aug; 88(8):1055-62. PubMed ID: 8401159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.